In the FLOW test, smeglutide can reduce the risk of renal failure events in type 2 diabetes patients with CKD by 18.7%, and the risk of continuous reduction of eGFR 50% by 22%
Ive learned a different way of living and eating better and longer. Luciana Down 150 pounds Its not magic, but its the support Ive needed to improve my health and my quality of life. Many patients have already tried commercial weight loss plans or online GLP-1 subscriptions with limited long-term success
J Biol Chem 274(13):86948697
Its no wonder, then, that when talking about weight loss today, discussion is dominated by the new GLP-1 (glucagon-like peptide-1) drugs
The evidence, however, does not strongly support this approach
That makes them a double-whammy winner, because protein is an appetite-tamer." Kimberly Gomer, RD, LDN For those using GLP-1 medications like semaglutide or tirzepatide, the protein in these legumes is particularly beneficial